This page is intended to provide reference information on AbbVie UK medicines for UK members of the public only.

Reference Information for AbbVie UK Medicines

In the list below, you can access links to the Electronic Medicines Compendium (eMC), an external resource which provides information about medicines available in the UK. 

RINVOQ® (upadacitinib)

VENCLYXTO® (venetoclax)

SYNAGIS® (PALIVIZUMAB)

DUODOPA® (levodopa/carbidopa intestinal gel)

MAVIRET® ▼ (glevaprevir/pibrentasvir)

 

Reporting of side effects:

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.

You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk. By reporting side effects you can help provide more information on the safety of these medicines.

For medicines with black triangle:

means the medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See https://yellowcard.mhra.gov.uk for how to report side effects.

AbbVie Ltd
AbbVie House
Vanwall Business Park
Vanwall Road
Maidenhead
Berkshire
SL6 4UB
UK Telephone: 01628 561090

UK-ABBV-210232

Date of preparation: August 2021

Copyright © 2019 AbbVie Ltd. All rights reserved. Registered Number: 08004972 England.